CMXI Financials 07/16/2014 15:34:49
Cytomedix, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 11,571 10,564 7,247 3,911
Cost of Revenue 8,453 3,915 2,727 1,613
Gross Profit 3,118 6,650 4,520 2,298
Operating Expenses
Research and Development 3,798 3,386 98 416
Sales, General and Admin. 17,415 16,158 7,936 7,285
Non-Recurring Items - - - -
Other - - - -
Operating Income (18,095) (12,895) (3,514) (5,403)
Income From Continuing Operations
Add'l Income/Expense Items (455) (5,844) 1,070 (601)
Earnings Before Interest and Tax (18,550) (18,739) (2,444) (6,004)
Interest Expense 1,680 1,042 1,048 799
Earnings Before Tax (20,230) (19,780) (3,493) (6,803)
Income Tax 19 18 18 14
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (20,248) (19,798) (3,511) (6,817)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (20,248) (19,798) (3,511) (6,817)
Preferred Stock and Other Adjustments - (14) (346) (2,223)
Net Income Applicable to Common Shareholders (20,248) (19,812) (3,857) (9,040)